Suppr超能文献

喹喔啉酮因子抑制剂在有丝分裂过程中破坏纺锤体和多个 LSF(TFCP2)-蛋白相互作用,包括与微管相关蛋白的相互作用。

Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.

机构信息

Department of Biology, Boston University, Boston, Massachusetts, United States of America.

Program in Molecular Biology, Cell Biology, and Biochemistry, Boston University, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2022 Jun 15;17(6):e0268857. doi: 10.1371/journal.pone.0268857. eCollection 2022.

Abstract

Factor quinolinone inhibitors (FQIs), a first-in-class set of small molecule inhibitors targeted to the transcription factor LSF (TFCP2), exhibit promising cancer chemotherapeutic properties. FQI1, the initial lead compound identified, unexpectedly induced a concentration-dependent delay in mitotic progression. Here, we show that FQI1 can rapidly and reversibly lead to mitotic arrest, even when added directly to mitotic cells, implying that FQI1-mediated mitotic defects are not transcriptionally based. Furthermore, treatment with FQIs resulted in a striking, concentration-dependent diminishment of spindle microtubules, accompanied by a concentration-dependent increase in multi-aster formation. Aberrant γ-tubulin localization was also observed. These phenotypes suggest that perturbation of spindle microtubules is the primary event leading to the mitotic delays upon FQI1 treatment. Previously, FQIs were shown to specifically inhibit not only LSF DNA-binding activity, which requires LSF oligomerization to tetramers, but also other specific LSF-protein interactions. Other transcription factors participate in mitosis through non-transcriptional means, and we recently reported that LSF directly binds α-tubulin and is present in purified cellular tubulin preparations. Consistent with a microtubule role for LSF, here we show that LSF enhanced the rate of tubulin polymerization in vitro, and FQI1 inhibited such polymerization. To probe whether the FQI1-mediated spindle abnormalities could result from inhibition of mitotic LSF-protein interactions, mass spectrometry was performed using as bait an inducible, tagged form of LSF that is biotinylated by endogenous enzymes. The global proteomics analysis yielded expected associations for a transcription factor, notably with RNA processing machinery, but also to nontranscriptional components. In particular, and consistent with spindle disruption due to FQI treatment, mitotic, FQI1-sensitive interactions were identified between the biotinylated LSF and microtubule-associated proteins that regulate spindle assembly, positioning, and dynamics, as well as centrosome-associated proteins. Probing the mitotic LSF interactome using small molecule inhibitors therefore supported a non-transcriptional role for LSF in mediating progression through mitosis.

摘要

喹啉酮类因子抑制剂(FQIs)是一类靶向转录因子 LSF(TFCP2)的小分子抑制剂,是一类首创的小分子抑制剂,具有有前景的癌症化疗特性。最初鉴定的先导化合物 FQI1 出人意料地导致有丝分裂进程呈浓度依赖性延迟。在这里,我们表明 FQI1 可以快速且可逆地导致有丝分裂停滞,即使在有丝分裂细胞中直接添加 FQI1 也是如此,这意味着 FQI1 介导的有丝分裂缺陷不是基于转录的。此外,用 FQIs 处理会导致明显的、浓度依赖性的纺锤体微管减少,同时多星形成的浓度依赖性增加。也观察到异常的 γ-微管蛋白定位。这些表型表明,在 FQI1 处理后导致有丝分裂延迟的主要事件是纺锤体微管的扰动。以前,已经表明 FQIs 不仅特异性抑制需要 LSF 寡聚形成四聚体的 LSF DNA 结合活性,而且还特异性抑制其他特定的 LSF-蛋白相互作用。其他转录因子通过非转录方式参与有丝分裂,我们最近报道 LSF 直接结合α-微管蛋白,并存在于纯化的细胞微管蛋白制剂中。与 LSF 对微管的作用一致,我们在这里表明 LSF 增强了体外微管蛋白聚合的速率,并且 FQI1 抑制了这种聚合。为了探究 FQI1 介导的纺锤体异常是否可能是由于抑制有丝分裂 LSF-蛋白相互作用,我们使用可诱导的、标记的 LSF 形式作为诱饵进行了质谱分析,该形式通过内源性酶被生物素化。全局蛋白质组学分析产生了一个转录因子的预期关联,特别是与 RNA 处理机制,但也与非转录成分有关。特别是,与由于 FQI 处理导致的纺锤体破坏一致,在生物素化的 LSF 与调节纺锤体组装、定位和动力学的微管相关蛋白以及中心体相关蛋白之间鉴定出有丝分裂、FQI1 敏感的相互作用。因此,使用小分子抑制剂探测有丝分裂 LSF 相互作用组支持 LSF 在介导有丝分裂进程中的非转录作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/9200292/e6a79ed8d754/pone.0268857.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验